Customization: | Available |
---|---|
Type: | IVD Reagent |
Certification: | CE, ISO13485 |
Still deciding? Get samples of US$ 1/pieces
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
BNP (B-type natriuretic peptide) is a cardiac biomarker primarily used to assess heart function and the severity of heart failure. It is released by cardiac cells, particularly in cardiac damage or heart failure cases, and helps regulate fluid balance and blood pressure by promoting sodium excretion and vasodilation.
In clinical practice, measuring BNP levels in the blood helps healthcare providers:
BNP is often measured alongside its precursor molecule, NT-proBNP (N-terminal pro-B-type natriuretic peptide), both valuable in diagnosing and managing heart failure.
Linear
Cal | Concentration | Result | AVERAGE |
S1 | 0.11 | 0.10 | 0.11 |
0.10 | |||
0.12 | |||
S2 | 0.53 | 0.53 | 0.52 |
0.46 | |||
0.58 | |||
S3 | 2.17 | 1.96 | 2.14 |
2.28 | |||
2.17 | |||
S4 | 10.1 | 9.28 | 10.64 |
12.04 | |||
10.59 | |||
S5 | 27.57 | 26.27 | 26.88 |
27.66 | |||
26.70 | |||
S6 | 39.32 | 41.69 | 42.73 |
44.67 | |||
41.82 |
Cal | Concentration | Cal | Concentration | Cal | Concentration |
R1 | 0.30 | R2 | 2.12 | R3 | 29.73 |
0.28 | 1.90 | 29.36 | |||
0.26 | 2.15 | 26.06 | |||
0.30 | 2.34 | 25.94 | |||
0.26 | 2.05 | 25.43 | |||
0.24 | 1.96 | 30.11 | |||
0.30 | 1.83 | 30.27 | |||
0.29 | 2.07 | 25.48 | |||
0.24 | 1.85 | 31.06 | |||
0.32 | 2.12 | 27.73 | |||
AVE | 0.28 | AVE | 2.04 | AVE | 28.12 |
SD | 0.03 | SD | 0.16 | SD | 2.23 |
CV | 9.7% | CV | 7.7% | CV | 7.9% |
Name | Quantity | Unit |
Test card with desiccant in a sealed foil pouch | 25 | tests |
Sample diluent | 25 | bottles |
ID chip | 1 | pcs |
Instruction for use | 1 | pcs |
Positive Result: Visible lines at both the control line (C) and the test line (T) on the test device indicate a positive result for BNP. This suggests the presence of elevated BNP concentration in the sample. Clinical correlation with other symptoms and tests is recommended for further evaluation.
Negative Result: Only the control line (C) is visible on the test device, with no line at the test region (T). This indicates a negative result for BNP, suggesting that BNP concentration was not detected in the sample. Clinical interpretation should consider additional diagnostic information.
Invalid Result: No visible colored band appears at the control line (C) on the test device. Possible reasons include insufficient sample volume, incorrect procedural technique, or use of expired test devices. It is advised to review the testing procedure and repeat with a new test device.
Item name | Test results | Clinical application recommendations |
BNP |
0~ 100pg/mL | Normal level |
>100pg/mL |
It indicates that the patient is at risk of congestive heart failure. |
Rapid test Kit-Colloidal gold |
|||
Chlamydia |
C. pneumoniae |
H. Pylori |
Malaria |
Rotavirus |
Adenovirus |
Rota/Adeno |
Strep A |
Syphilis |
HBsAg |
HBsAb |
HBsAg and HCV |
HBsAg /HCV /HIV /Syphilis |
Dengue IgG/IgM |
Dengue Ns1 |
Dengue IgG/IgM /NS1 |
Chikungunya |
Cholera |
Typhoid |
Tuberculosis |
HIV1+2 |
HIV1+2 Ag/Ab |
SEA |
ToRCH |
HCV |
HSV |
RSV |
TOXO |
Rubella |
CMV |
Norovirus |
Leishmania |
Filariasis |
Leptospira |
Monkeypox |
M.Pneumoniae |
Chagas |
Brucella |
HPV |
|
Influenza A+B |
Influenza A+B |
Influenza A+B/RSV |
FOB |
AMH |
AMH/FSH |
MxA |
cTnI |
HCG | LH | 25-OH VD | |
The Customized cut -off and sizes are available |
Lateral Flow Quantitive Test Kit | |||
Class |
Rapid Test |
Sample type |
Detection Range |
Cardiac Marker |
cTn I |
Serum/Plasma/Whole blood |
0.1~40 ng/mL |
NT-proBNP |
Serum/Plasma/Whole blood |
100~20000 pg/mL |
|
CK-MB |
Serum/Plasma/Whole blood |
1ng/mL~100ng/mL |
|
BNP |
Plasma/Whole blood |
5pg/mL~5000pg/mL |
|
cTnT |
Serum/Plasma/Whole blood |
30pg/mL~25000pg/mL |
|
Myo |
Serum/Plasma/Whole blood |
5ng/mL~500ng/mL |
|
cTnl/ Myo/ CK-MB |
Serum/Plasma/Whole blood |
cTnI: 0.1ng/mL~40ng/mL;Myo: 5ng/mL~500ng/mL;CK-MB: 1ng/mL~100ng/mL |
|
D-Dimer/ cTnI/ NT-proBNP |
Serum/Plasma/Whole blood |
Dimer: 0.1mg/L~10mg/L; cTnI: 0.1ng/mL~40ng/mL; NT-proBNP: 100pg/mL~20000pg/mL |
|
Inflammatory |
PCT |
Serum/Plasma/Whole blood |
0.1~100 pg/mL |
CRP |
Serum/Plasma/Whole blood |
0.5~200mg/L |
|
SAA |
Serum/Plasma/Whole blood |
5~300mg/L |
|
IL-6 |
Serum/Plasma/Whole blood |
5~5000 pg/mL |
|
PCT/ IL-6 |
Serum/Plasma/Whole blood |
PCT: 0.1ng/mL~100ng/mL;IL-6:10pg/mL~10000pg/mL |
|
CRP/ SAA |
Serum/Plasma/Whole blood |
CRP 0.5mg/L~200mg/L;SAA 5mg/L~300mg/L, |
|
Glycated hemoglobin |
HbA1c |
Whole blood |
3~14% |
Tumor |
PSA |
Serum/Plasma/Whole blood |
2~80 ng/mL |
HCG |
HCG |
Serum/Plasma/Whole blood |
5~200000mIU/mL |
Anticoagulation |
D-Dimer |
Plasma/Whole blood |
0.1~10 mg/L |
Endocrine |
TSH |
Serum/Plasma/Whole blood |
0.1mIU/L ~100.0mIU/L |
T3 |
Serum/Plasma/Whole blood |
0.61~9.22 nmol/L |
|
T4 |
Serum/Plasma/Whole blood |
12.87~310 nmol/L |
|
FT3 |
Serum/Plasma/Whole blood |
0.60pmol/L ~45.00pmol/L |
|
FT4 |
Serum/Plasma/Whole blood |
1.00pmol/L ~100.00pmol/L |
|
AMH |
Serum/Plasma/Whole blood |
0.1~16 ng/mL |
|
PROG |
Serum/Plasma |
0.35ng/mL~60ng/mL |
|
PRL |
Serum/Plasma/Whole blood |
1 ng/mL~200ng/mL |
|
FSH |
Serum/Plasma/Whole blood |
1mIU/mL~100 mIU/mL |
|
LH |
Serum/Plasma/Whole blood |
1 ~100 mIU/mL |
|
TES |
Serum/Plasma |
0.2~15 ng/mL |
|
E2 |
Serum/Plasma/Whole blood |
15 pg/mL~3000pg/mL |
|
Bone |
25-OH-VD |
Serum/Plasma/Whole blood |
5.0ng/mL~100.0ng/mL |
The Customized cut -off and size are available |